Orexin Receptor Antagonist
6 drugs across 2 manufacturers|0 Generic,6 Brand
The Orexin Receptor Antagonist class contains 6 NDCs from 2 manufacturers (0 generic, 6 brand), at an average NADAC of $14.00 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
6
0G / 6B
Manufacturers
2
Avg $13.9982/unit
Avg 7d Change
+0.03%
Across 6 drugs with changes
7d Activity
of 6 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BELSOMRA 5 MG TABLET suvorexant | $15.2138 per EA | +0.07% |
BELSOMRA 10 MG TABLET suvorexant | $15.2097 per EA | +0.01% |
BELSOMRA 20 MG TABLET suvorexant | $15.2070 per EA | +0.01% |
BELSOMRA 15 MG TABLET suvorexant | $15.1988 per EA | +0.04% |
DAYVIGO 5 MG TABLET lemborexant | $11.5802 per EA | -0.02% |
DAYVIGO 10 MG TABLET lemborexant | $11.5794 per EA | -0.02% |
Frequently Asked Questions
How many drugs are in the Orexin Receptor Antagonist class?
The Orexin Receptor Antagonist class contains 6 NDCs from 2 manufacturers — 0 generic and 6 brand products.
What is the average price of Orexin Receptor Antagonist drugs?
The average NADAC for the Orexin Receptor Antagonist class is $13.9982 per unit across 6 NDCs.
Which manufacturers make Orexin Receptor Antagonist drugs?
2 manufacturers make drugs in the Orexin Receptor Antagonist class. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (4), Eisai Inc. (2).
How has Orexin Receptor Antagonist pricing changed recently?
Over the past 7 days, 4 NDCs in this class rose and 2 fell, with a class-wide average change of +0.0%.